Kane Biotech Receives an Additional $425K USD of Funding for its DispersinB® Hydrogel from the United States Department of Defense Oct 4, 2022
Kane Biotech to Release Second Quarter 2022 Financial Results on August 25, 2022 – Conference Call to Follow Aug 18, 2022
Kane Biotech Announces Adoption of Amended and Restated Stock Option Plan and Performance and Restricted Share Unit Plan Jun 30, 2022
Kane Biotech to Release First Quarter 2022 Financial Results on May 26 – Conference Call to Follow May 19, 2022
